{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["20(R)-ginsenosides", "UDP-glycosyltransferase", "biosynthesis", "ginsenoside"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "30662300", "DateRevised": {"Year": "2024", "Month": "05", "Day": "23"}, "Article": {"ArticleDate": [{"Year": "2017", "Month": "10", "Day": "16"}], "Language": ["eng"], "ELocationID": ["10.1016/j.jgr.2017.09.005"], "Journal": {"ISSN": "1226-8453", "JournalIssue": {"Volume": "43", "Issue": "1", "PubDate": {"Year": "2019", "Month": "Jan"}}, "Title": "Journal of ginseng research", "ISOAbbreviation": "J Ginseng Res"}, "ArticleTitle": "Biosynthesis of rare 20(<i>R</i>)-protopanaxadiol/protopanaxatriol type ginsenosides through <i>Escherichia coli</i> engineered with uridine diphosphate glycosyltransferase genes.", "Pagination": {"StartPage": "116", "EndPage": "124", "MedlinePgn": "116-124"}, "Abstract": {"AbstractText": ["Ginsenosides are known as the principal pharmacological active constituents in <i>Panax</i> medicinal plants such as Asian ginseng, American ginseng, and Notoginseng. Some ginsenosides, especially the 20(<i>R</i>) isomers, are found in trace amounts in natural sources and are difficult to chemically synthesize. The present study provides an approach to produce such trace ginsenosides applying biotransformation through <i>Escherichia coli</i> modified with relevant genes.", "Seven uridine diphosphate glycosyltransferase (UGT) genes originating from <i>Panax notoginseng</i>, <i>Medicago sativa</i>, and <i>Bacillus subtilis</i> were synthesized or cloned and constructed into pETM6, an ePathBrick vector, which were then introduced into <i>E.\u00a0coli</i> BL21star (DE3) separately. 20(<i>R</i>)-Protopanaxadiol (PPD), 20(<i>R</i>)-protopanaxatriol (PPT), and 20(<i>R</i>)-type ginsenosides were used as substrates for biotransformation with recombinant <i>E.\u00a0coli</i> modified with those <i>UGT</i> genes.", "<i>E.\u00a0coli</i> engineered with <i>GT95</i> <sup><i>syn</i></sup> selectively transfers a glucose moiety to the C20 hydroxyl of 20(<i>R</i>)-PPD and 20(<i>R</i>)-PPT to produce 20(<i>R</i>)-CK and 20(<i>R</i>)-F1, respectively. <i>GTK1-</i> and <i>GTC1</i>-modified <i>E.\u00a0coli</i> glycosylated the C3-OH of 20(<i>R</i>)-PPD to form 20(<i>R</i>)-Rh2. Moreover, <i>E.\u00a0coli</i> containing p2GT95<sup>syn</sup>K1, a recreated two-step glycosylation pathway via the ePathBrich, implemented the successive glycosylation at C20-OH and C3-OH of 20(<i>R</i>)-PPD and yielded 20(<i>R</i>)-F2 in the biotransformation broth.", "This study demonstrates that rare 20(<i>R</i>)-ginsenosides can be produced through <i>E.\u00a0coli</i> engineered with UTG genes."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang, China."}, {"Identifier": [], "Affiliation": "Shanghai Key Laboratory of Compound Chinese Medicines, Institute of Chinese Materia Medica, MOE Key Laboratory for Standardization of Chinese Medicines, SATCM Key Laboratory for New Resources and Quality Evaluation of Chinese Medicines, Shanghai University of Traditional Chinese Medicine, Shanghai, China."}], "LastName": "Yu", "ForeName": "Lu", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Shanghai Key Laboratory of Compound Chinese Medicines, Institute of Chinese Materia Medica, MOE Key Laboratory for Standardization of Chinese Medicines, SATCM Key Laboratory for New Resources and Quality Evaluation of Chinese Medicines, Shanghai University of Traditional Chinese Medicine, Shanghai, China."}], "LastName": "Chen", "ForeName": "Yuan", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Shanghai Key Laboratory of Compound Chinese Medicines, Institute of Chinese Materia Medica, MOE Key Laboratory for Standardization of Chinese Medicines, SATCM Key Laboratory for New Resources and Quality Evaluation of Chinese Medicines, Shanghai University of Traditional Chinese Medicine, Shanghai, China."}], "LastName": "Shi", "ForeName": "Jie", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Shanghai Key Laboratory of Compound Chinese Medicines, Institute of Chinese Materia Medica, MOE Key Laboratory for Standardization of Chinese Medicines, SATCM Key Laboratory for New Resources and Quality Evaluation of Chinese Medicines, Shanghai University of Traditional Chinese Medicine, Shanghai, China."}], "LastName": "Wang", "ForeName": "Rufeng", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Shanghai Key Laboratory of Compound Chinese Medicines, Institute of Chinese Materia Medica, MOE Key Laboratory for Standardization of Chinese Medicines, SATCM Key Laboratory for New Resources and Quality Evaluation of Chinese Medicines, Shanghai University of Traditional Chinese Medicine, Shanghai, China."}], "LastName": "Yang", "ForeName": "Yingbo", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Shanghai Key Laboratory of Compound Chinese Medicines, Institute of Chinese Materia Medica, MOE Key Laboratory for Standardization of Chinese Medicines, SATCM Key Laboratory for New Resources and Quality Evaluation of Chinese Medicines, Shanghai University of Traditional Chinese Medicine, Shanghai, China."}], "LastName": "Yang", "ForeName": "Li", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Shanghai Key Laboratory of Compound Chinese Medicines, Institute of Chinese Materia Medica, MOE Key Laboratory for Standardization of Chinese Medicines, SATCM Key Laboratory for New Resources and Quality Evaluation of Chinese Medicines, Shanghai University of Traditional Chinese Medicine, Shanghai, China."}], "LastName": "Zhao", "ForeName": "Shujuan", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang, China."}, {"Identifier": [], "Affiliation": "Shanghai Key Laboratory of Compound Chinese Medicines, Institute of Chinese Materia Medica, MOE Key Laboratory for Standardization of Chinese Medicines, SATCM Key Laboratory for New Resources and Quality Evaluation of Chinese Medicines, Shanghai University of Traditional Chinese Medicine, Shanghai, China."}], "LastName": "Wang", "ForeName": "Zhengtao", "Initials": "Z"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Korea (South)", "MedlineTA": "J Ginseng Res", "NlmUniqueID": "100890690", "ISSNLinking": "1226-8453"}}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Nicol R.W., Traquair J.A., Bernards M.A. Ginsenosides as host resistance factors in American ginseng (Panax quinquefolius) Can J Bot. 2011;80:557\u2013562."}, {"Citation": "Cho W.C.S., Chung W.S., Lee S.K.W., Leung A.W.N., Cheng C.H.K. Ginsenoside Re of Panax ginseng possesses significant antioxidant and antihyperlipidemic efficacies in streptozotocin-induced diabetic rats. Eur J Pharmacol. 2006;550:173\u2013179.", "ArticleIdList": ["0"]}, {"Citation": "Wang T., Guo R.X., Zhou G.H., Zhou X.D., Kou Z.Z., Sui F., Li C., Tang L.Y., Wang Z.J. Traditional uses, botany, phytochemistry, pharmacology and toxicology of Panax notoginseng (Burk.) F.H. Chen: a review. J\u00a0Ethnopharmacol. 2016;188:234\u2013258.", "ArticleIdList": ["27154405"]}, {"Citation": "Yang W.Z., Hu Y., Wu W.Y., Ye M., Guo D.A. Saponins in the genus Panax L. (Araliaceae): a systematic review of their chemical diversity. Phytochemistry. 2014;106:7\u201324.", "ArticleIdList": ["25108743"]}, {"Citation": "Gao B., Huang L.F., Liu H.S., Wu H., Zhang E.Y., Yang L., Wu X.J., Wang Z.T. Platelet P2Y12 receptor involved in the hemostatic effect of notoginsenoside Ft1, a saponin isolated from Panax notoginseng. Br J Pharmacol. 2014;171:214\u2013223.", "ArticleIdList": ["PMC3874708", "24117220"]}, {"Citation": "Gao B., Shi H.L., Li X., Qiu S.P., Wu H., Zhang B.B., Wu X.J., Wang Z.T. p38 MAPK and ERK1/2 pathways are involved in the pro-apoptotic effect of notoginsenoside Ft1 on human neuroblastoma SH-SY5Y cells. Life Sci. 2014;108:63\u201370.", "ArticleIdList": ["24857982"]}, {"Citation": "Shen K.K., Ji L.L., Gong C.Y., Ma Y.B., Yang L., Fan Y., Hou M.Q., Wang Z.T. Notoginsenoside Ft1 promotes angiogenesis via HIF-1\u03b1 mediated VEGF secretion and the regulation of PI3K/AKT and Raf/MEK/ERK signaling pathways. Biochem Pharmacol. 2012;84:784\u2013792.", "ArticleIdList": ["22771629"]}, {"Citation": "Shen K.K., Leung S.W.S., Ji L.L., Huang Y., Hou M.Q., Xu A.M., Wang Z.T., Vanhoutte P.M. Notoginsenoside Ft1 activates both glucocorticoid and estrogen receptors to induce endothelium-dependent, nitric oxide-mediated relaxations in rat mesenteric arteries. Biochem Pharmacol. 2014;88:66\u201374.", "ArticleIdList": ["24440742"]}, {"Citation": "Zhang J.J., Ding L.L., Wang B.C., Ren G.Y., Sun A.N., Deng C., Wei X.H., Mani S., Wang Z.T., Dou W. Notoginsenoside R1 attenuates experimental inflammatory bowel disease via pregnane X receptor activation. J\u00a0Pharmacol Exp Ther. 2015;352:1\u201310.", "ArticleIdList": ["PMC4293438", "25472953"]}, {"Citation": "Deng J., Jiang Y.X., Ying-Li C., Chen X.Q. Effects of ginsenoside CK on gastric cancer SGC-7901 cell line and endogenous VEGF secreted by tumor cells. Cancer Res Prev Treat. 2011;38:17\u201320."}, {"Citation": "Oh M., Choi Y.H., Choi S., Chung H., Kim K. Anti-proliferating effects of ginsenoside Rh2 on MCF-7 human breast cancer cells. Int J Oncol. 1999;14:869\u2013875.", "ArticleIdList": ["10200336"]}, {"Citation": "Tsutsumi Y.M., Tsutsumi R., Mawatari K., Nakaya Y., Kinoshita M., Tanaka K., Oshita S., Compound K. A\u00a0metabolite of ginsenosides, induces cardiac protection mediated nitric oxide via Akt/PI3K pathway. Life Sci. 2011;88:725\u2013729.", "ArticleIdList": ["21338613"]}, {"Citation": "Shin K.O., Seo C.H., Cho H.H. Ginsenoside compound K inhibits angiogenesis via regulation of sphingosine kinase-1 in human umbilical vein endothelial cells. Arch Pharmacol Res. 2014;37:1183\u20131192.", "ArticleIdList": ["24687256"]}, {"Citation": "Mai T.T., Moon J.Y., Song Y.W. Ginsenoside F2 induces apoptosis accompanied by protective autophagy in breast cancer stem cells. Cancer Lett. 2012;321:144\u2013153.", "ArticleIdList": ["22326284"]}, {"Citation": "Siraj F.M., SathishKumar N., Kim Y.J. Ginsenoside F2 possesses anti-obesity activity via binding with PPAR and inhibiting adipocyte differentiation in the 3T3-L1 cell line. J\u00a0Enzym Inhib Med Ch. 2014;30:9\u201314.", "ArticleIdList": ["24666293"]}, {"Citation": "Wei X.J., Chen J., Su F., Su X.Y., Hu T.J., Hu S.H. Stereospecificity of ginsenoside Rg3 in promotion of the immune response to ovalbumin in mice. Int Immunol. 2012;24:465\u2013471.", "ArticleIdList": ["22427454"]}, {"Citation": "Pi M.S., Ru Q., Gong X.K., Wu R.H., Tian X., Xiong Q., Li C.Y. Effect of ginsenoside Rg2 and its stereoisomers on oxygen-glucose deprivation and reperfusion induced cortical neuronal injury model. Chin J Integr Tradit West Med. 2016;36:333\u2013338.", "ArticleIdList": ["27236892"]}, {"Citation": "Yang X.D., Yang Y.Y., Ouyang D.S., Yang G.P. A\u00a0review of biotransformation and pharmacology of ginsenoside compound K. Fitoterapia. 2015;100:208\u2013220.", "ArticleIdList": ["25449425"]}, {"Citation": "Yan Q., Zhou X.W., Zhou W., Li X.W., Feng M.Q., Zhou P. Purification and properties of a novel beta-glucosidase, hydrolyzing ginsenoside Rb1 to CK, from Paecilomyces bainier. J\u00a0Microbiol Biotechnol. 2008;18:1081\u20131089.", "ArticleIdList": ["18600051"]}, {"Citation": "Bae E.A., Choo M.K., Park E.K., Park S.Y., Shin H.Y., Kim D.H. Metabolism of ginsenoside R(c) by human intestinal bacteria and its related antiallergic activity. Biol Pharm Bull. 2002;25:743\u2013747.", "ArticleIdList": ["12081140"]}, {"Citation": "Zhou W., Feng M.Q., Li J.Y., Zhou P. Studies on the preparation, crystal structure and bioactivity of ginsenoside compound K. J\u00a0Asian Nat Prod Res. 2006;8:519\u2013527.", "ArticleIdList": ["16931427"]}, {"Citation": "Quan L.H., Kim Y.J., Li G.H., Choi K.T., Yang D.C. Microbial transformation of ginsenoside Rb1 to compound K by Lactobacillus paralimentarius. World J Microbiol Biotechnol. 2013;29:1001\u20131007.", "ArticleIdList": ["23338962"]}, {"Citation": "Wang R.F., Zheng M.M., Cao Y.D., Li H., Li C.X., Xu J.H., Wang Z.T. Enzymatic transformation of vina-ginsenoside R7 to rare notoginsenoside ST-4 using a new recombinant gylcoside hydrolase from Herpetosiphon aurantiacus. Appl Microbiol Biotechnol. 2015;99:3433\u20133442.", "ArticleIdList": ["25676336"]}, {"Citation": "Wang R.F., Li J., Hu H.J., Li J., Yang Y.B., Yang L., Wang Z.T. Chemical transformation and target preparation of saponins in stems and leaves of Panax notoginseng. J\u00a0Ginseng Res. 2018;42:270\u2013276.", "ArticleIdList": ["PMC6026369", "29983608"]}, {"Citation": "Yan X., Fan Y., Wei W., Wang P.P., Liu Q.F., Wei Y.J., Zhang L., Zhao G.P., Yue J.M., Zhou Z.H. Production of bioactive ginsenoside compound K in metabolically engineered yeast. Cell Res. 2014;24:770\u2013773.", "ArticleIdList": ["PMC4042165", "24603359"]}, {"Citation": "Liu M.H., Yang B.R., Cheung W.F., Yang K.Y., Zhou H.F., Kwok J.S., Liu G.C., Li X.F., Zhong S., Lee S.M. Transcriptome analysis of leaves, roots and flowers of Panax notoginseng identifies genes involved in ginsenoside and alkaloid biosynthsis. BMC Genomics. 2015;16:1\u201312.", "ArticleIdList": ["PMC4399409", "25886736"]}, {"Citation": "Luo S.L., Dang L.Z., Zhang K.Q., Liang L.M., Li G.H. Cloning and heterologous expression of UDP-glycosyltransferase genes from Bacillus subtilis and its application in the glycosylation of ginsenoside Rh1. Lett Appl Microbiol. 2014;60:72\u201378.", "ArticleIdList": ["25327709"]}, {"Citation": "Xu P., Vansiri A., Bhan N., Koffas M.A.G. ePathBrick: a synthetic biology platform for engineering metabolic pathways in E.\u00a0coli. ACS Synth Biol. 2012;1:256\u2013266.", "ArticleIdList": ["23651248"]}, {"Citation": "Zhao S.J., Jones J.A., Lachance D.M., Bhan N., Khalidi O., Venkataraman S., Wang Z.T., Koffas M.A. Improvement of catechin production in Escherichia coli through combinatorial metabolic engineering. Metab Eng. 2015;28:43\u201353.", "ArticleIdList": ["25527438"]}, {"Citation": "Liu L., Zhu X.M., Wang Q.J., Zhang D.L., Fang Z.M., Wang C.Y., Wang Z., Sun B.S., Wu H., Sung C.K. Enzymatic preparation of 20(S, R)-protopanaxadiol by transformation of 20(S,R)-Rg3 from black ginseng. Phytochemistry. 2010;71:1514\u20131520.", "ArticleIdList": ["20576280"]}, {"Citation": "Wang P.P., Wei Y.J., Fan Y., Liu Q.F., Wei W., Yang C.S., Zhang L., Zhao G.P., Yue J.M., Yan X. Production of bioactive ginsenosides Rh2 and Rg3 by metabolically engineered yeasts. Metab Eng. 2015;29:97\u2013105.", "ArticleIdList": ["25769286"]}, {"Citation": "Jung S.C., Kim W., Park S.C., Jeong J., Park M.K., Lim S., Lee Y., Im W.T., Lee J.H., Choi G. Two ginseng UDP-glycosyltransferases synthesize ginsenoside Rg3 and Rd. Plant Cell Physiol. 2014;55:2177\u20132188.", "ArticleIdList": ["25320211"]}]}], "History": [{"Year": "2016", "Month": "10", "Day": "24"}, {"Year": "2017", "Month": "7", "Day": "7"}, {"Year": "2017", "Month": "9", "Day": "18"}, {"Year": "2019", "Month": "1", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "1", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "1", "Day": "22", "Hour": "6", "Minute": "1"}, {"Year": "2017", "Month": "10", "Day": "16"}], "PublicationStatus": "ppublish", "ArticleIdList": ["30662300", "PMC6323243", "10.1016/j.jgr.2017.09.005", "S1226-8453(16)30244-5"]}}]}